[1]
Erdem H, Inan A, Guven E, Hargreaves S, Larsen L, Shehata G, Pernicova E, Khan E, Bastakova L, Namani S, Harxhi A, Roganovic T, Lakatos B, Uysal S, Sipahi OR, Crisan A, Miftode E, Stebel R, Jegorovic B, Fehér Z, Jekkel C, Pandak N, Moravveji A, Yilmaz H, Khalifa A, Musabak U, Yilmaz S, Jouhar A, Oztoprak N, Argemi X, Baldeyrou M, Bellaud G, Moroti RV, Hasbun R, Salazar L, Tekin R, Canestri A, Čalkić L, Praticò L, Yilmaz-Karadag F, Santos L, Pinto A, Kaptan F, Bossi P, Aron J, Duissenova A, Shopayeva G, Utaganov B, Grgic S, Ersoz G, Wu AKL, Lung KC, Bruzsa A, Radic LB, Kahraman H, Momen-Heravi M, Kulzhanova S, Rigo F, Konkayeva M, Smagulova Z, Tang T, Chan P, Ahmetagic S, Porobic-Jahic H, Moradi F, Kaya S, Cag Y, Bohr A, Artuk C, Celik I, Amsilli M, Gul HC, Cascio A, Lanzafame M, Nassar M. The burden and epidemiology of community-acquired central nervous system infections: a multinational study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2017 Sep:36(9):1595-1611. doi: 10.1007/s10096-017-2973-0. Epub 2017 Apr 10
[PubMed PMID: 28397100]
[2]
Leonard JM. Central Nervous System Tuberculosis. Microbiology spectrum. 2017 Mar:5(2):. doi: 10.1128/microbiolspec.TNMI7-0044-2017. Epub
[PubMed PMID: 28281443]
[3]
Ingole R, Garg RK, Malhotra HS, Jain A, Kumar N, Rizvi I, Garg R. Spectrum of central nervous system tuberculosis: An experience from a large tertiary care institution of India. The Indian journal of tuberculosis. 2019 Jan:66(1):49-57. doi: 10.1016/j.ijtb.2017.05.011. Epub 2017 Jun 16
[PubMed PMID: 30797283]
[4]
Schaller MA, Wicke F, Foerch C, Weidauer S. Central Nervous System Tuberculosis : Etiology, Clinical Manifestations and Neuroradiological Features. Clinical neuroradiology. 2019 Mar:29(1):3-18. doi: 10.1007/s00062-018-0726-9. Epub 2018 Sep 17
[PubMed PMID: 30225516]
[5]
Török ME. Tuberculous meningitis: advances in diagnosis and treatment. British medical bulletin. 2015 Mar:113(1):117-31. doi: 10.1093/bmb/ldv003. Epub 2015 Feb 18
[PubMed PMID: 25693576]
Level 3 (low-level) evidence
[6]
Davis AG, Rohlwink UK, Proust A, Figaji AA, Wilkinson RJ. The pathogenesis of tuberculous meningitis. Journal of leukocyte biology. 2019 Feb:105(2):267-280. doi: 10.1002/JLB.MR0318-102R. Epub 2019 Jan 15
[PubMed PMID: 30645042]
[7]
Guleria R, Kavitha. Central nervous system tuberculosis. The Indian journal of tuberculosis. 2014 Jul:61(3):195-9
[PubMed PMID: 25241567]
[8]
Imran D, Estiasari R, Maharani K, Sucipto, Lestari DC, Yunus RE, Yunihastuti E, Karyadi TH, Oei D, Timan IS, Wulandari D, Wahyuningsih R, Adawiyah R, Kurniawan A, Mulyadi R, Karuniawati A, Jaya UA, Safari D, van Laarhoven A, Alisjahbana B, Dian S, Chaidir L, Ganiem AR, Lastri DN, Aye Myint KS, van Crevel R. Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study. Neurology. Clinical practice. 2018 Oct:8(5):379-388. doi: 10.1212/CPJ.0000000000000517. Epub
[PubMed PMID: 30564491]
[9]
Patkar D, Narang J, Yanamandala R, Lawande M, Shah GV. Central nervous system tuberculosis: pathophysiology and imaging findings. Neuroimaging clinics of North America. 2012 Nov:22(4):677-705. doi: 10.1016/j.nic.2012.05.006. Epub 2012 Aug 11
[PubMed PMID: 23122262]
[10]
Chin JH. Tuberculous meningitis: A neglected tropical disease? Neurology. Clinical practice. 2019 Apr:9(2):152-154. doi: 10.1212/CPJ.0000000000000606. Epub
[PubMed PMID: 31041130]
[11]
Deutsch-Feldman M, Pratt RH, Price SF, Tsang CA, Self JL. Tuberculosis - United States, 2020. MMWR. Morbidity and mortality weekly report. 2021 Mar 26:70(12):409-414. doi: 10.15585/mmwr.mm7012a1. Epub 2021 Mar 26
[PubMed PMID: 33764959]
[12]
Filardo TD, Feng PJ, Pratt RH, Price SF, Self JL. Tuberculosis - United States, 2021. MMWR. Morbidity and mortality weekly report. 2022 Mar 25:71(12):441-446. doi: 10.15585/mmwr.mm7112a1. Epub 2022 Mar 25
[PubMed PMID: 35324877]
[13]
Rieder HL, Snider DE Jr, Cauthen GM. Extrapulmonary tuberculosis in the United States. The American review of respiratory disease. 1990 Feb:141(2):347-51
[PubMed PMID: 2301852]
[14]
Moule MG, Cirillo JD. Mycobacterium tuberculosis Dissemination Plays a Critical Role in Pathogenesis. Frontiers in cellular and infection microbiology. 2020:10():65. doi: 10.3389/fcimb.2020.00065. Epub 2020 Feb 25
[PubMed PMID: 32161724]
[15]
Dastur DK, Manghani DK, Udani PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiologic clinics of North America. 1995 Jul:33(4):733-52
[PubMed PMID: 7610242]
[16]
Cherian A, Ajitha KC, Iype T, Divya KP. Neurotuberculosis: an update. Acta neurologica Belgica. 2021 Feb:121(1):11-21. doi: 10.1007/s13760-020-01575-0. Epub 2021 Jan 5
[PubMed PMID: 33400226]
[17]
Bhargava S, Gupta AK, Tandon PN. Tuberculous meningitis--a CT study. The British journal of radiology. 1982 Mar:55(651):189-96
[PubMed PMID: 7066619]
[18]
Kent SJ, Crowe SM, Yung A, Lucas CR, Mijch AM. Tuberculous meningitis: a 30-year review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1993 Dec:17(6):987-94
[PubMed PMID: 8110957]
[19]
Thomas MD, Chopra JS, Walia BN. Tuberculous meningitis (T.B.M.)(a clinical study of 232 cases). The Journal of the Association of Physicians of India. 1977 Sep:25(9):633-9
[PubMed PMID: 612660]
Level 3 (low-level) evidence
[20]
Salvador GLO, Basso ACN, Barbieri PP, Leitao CA, Teixeira BCA, Neto AC. Central nervous system and spinal cord tuberculosis: Revisiting an important disease. Clinical imaging. 2021 Jan:69():158-168. doi: 10.1016/j.clinimag.2020.07.020. Epub 2020 Jul 29
[PubMed PMID: 32853843]
[21]
Kocen RS, Parsons M. Neurological complications of tuberculosis: some unusual manifestations. The Quarterly journal of medicine. 1970 Jan:39(153):17-30
[PubMed PMID: 5427330]
[22]
Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, González-LaHoz J, Bouza E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. The New England journal of medicine. 1992 Mar 5:326(10):668-72
[PubMed PMID: 1346547]
[23]
Méchaï F, Bouchaud O. Tuberculous meningitis: Challenges in diagnosis and management. Revue neurologique. 2019 Sep-Oct:175(7-8):451-457. doi: 10.1016/j.neurol.2019.07.007. Epub 2019 Aug 2
[PubMed PMID: 31383464]
[24]
Wilkinson RJ, Rohlwink U, Misra UK, van Crevel R, Mai NTH, Dooley KE, Caws M, Figaji A, Savic R, Solomons R, Thwaites GE, Tuberculous Meningitis International Research Consortium. Tuberculous meningitis. Nature reviews. Neurology. 2017 Oct:13(10):581-598. doi: 10.1038/nrneurol.2017.120. Epub 2017 Sep 8
[PubMed PMID: 28884751]
[25]
Marais S, Thwaites G, Schoeman JF, Török ME, Misra UK, Prasad K, Donald PR, Wilkinson RJ, Marais BJ. Tuberculous meningitis: a uniform case definition for use in clinical research. The Lancet. Infectious diseases. 2010 Nov:10(11):803-12. doi: 10.1016/S1473-3099(10)70138-9. Epub 2010 Sep 6
[PubMed PMID: 20822958]
Level 3 (low-level) evidence
[26]
Kim MC, Park KH, Lee SA, Kim SH. Validation of the Uniform Case Definition Criteria for Differentiating Tuberculous Meningitis, Viral Meningitis, and Bacterial Meningitis in Adults. Infection & chemotherapy. 2019 Jun:51(2):188-190. doi: 10.3947/ic.2019.51.2.188. Epub
[PubMed PMID: 31270999]
Level 3 (low-level) evidence
[27]
Munakomi S, Grasso G, Chapagain R. Multi-spectral Pattern of Clinical Presentation and the Resultant Outcome in Central Nervous System Tuberculosis: A Single Center Study on the Ubiquitous Pathogen. Advances in experimental medicine and biology. 2020:1271():29-35. doi: 10.1007/5584_2019_466. Epub
[PubMed PMID: 31994016]
Level 3 (low-level) evidence
[28]
Verma R, Sarkar S, Garg RK, Malhotra HS, Sharma PK, Saxena S. Ophthalmological manifestation in patients of tuberculous meningitis. QJM : monthly journal of the Association of Physicians. 2019 Jun 1:112(6):409-419. doi: 10.1093/qjmed/hcz037. Epub
[PubMed PMID: 30722057]
[29]
Stadelman AM, Ssebambulidde K, Buller A, Tugume L, Yuquimpo K, Bakker CJ, Boulware DR, Bahr NC. Cerebrospinal fluid AFB smear in adults with tuberculous meningitis: A systematic review and diagnostic test accuracy meta-analysis. Tuberculosis (Edinburgh, Scotland). 2022 Jul:135():102230. doi: 10.1016/j.tube.2022.102230. Epub 2022 Jun 24
[PubMed PMID: 35779498]
Level 1 (high-level) evidence
[30]
Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. The Cochrane database of systematic reviews. 2018 Aug 27:8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2. Epub 2018 Aug 27
[PubMed PMID: 30148542]
Level 1 (high-level) evidence
[31]
Wakode P, Siddaiah N, Manjunath N, Bahubali VKH. GeneXpert: A Rapid and Supplementary Diagnostic Tool for Tuberculous Meningitis, Experience from Tertiary Neurocenter. Journal of neurosciences in rural practice. 2022 Apr:13(2):204-210. doi: 10.1055/s-0041-1742138. Epub 2022 Feb 18
[PubMed PMID: 35694081]
[32]
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD. Rapid molecular detection of tuberculosis and rifampin resistance. The New England journal of medicine. 2010 Sep 9:363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1
[PubMed PMID: 20825313]
[33]
Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, Bridge SC, Bangdiwala AS, Meya DB, Denkinger CM, Muzoora C, Boulware DR, ASTRO-CM Trial Team. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. The Lancet. Infectious diseases. 2018 Jan:18(1):68-75. doi: 10.1016/S1473-3099(17)30474-7. Epub 2017 Sep 14
[PubMed PMID: 28919338]
[34]
Rajput R, Singh P, Sarin R, Sethi P, Sharma S. Diagnostic accuracy of loop-mediated isothermal amplification assay for extra-pulmonary tuberculosis in Indian population. Journal of microbiological methods. 2019 Mar:158():59-65. doi: 10.1016/j.mimet.2019.01.016. Epub 2019 Jan 28
[PubMed PMID: 30703448]
[35]
Quinn CM, Kagimu E, Okirworth M, Bangdiwala AS, Mugumya G, Ramachandran PS, Wilson MR, Meya DB, Cresswell FV, Bahr NC, Boulware DR. Fujifilm SILVAMP TB LAM Assay on Cerebrospinal Fluid for the Detection of Tuberculous Meningitis in Adults With Human Immunodeficiency Virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Nov 2:73(9):e3428-e3434. doi: 10.1093/cid/ciaa1910. Epub
[PubMed PMID: 33388751]
[36]
Siddiqi OK, Birbeck GL, Ghebremichael M, Mubanga E, Love S, Buback C, Kosloff B, Ayles H, Atadzhanov M, Dheda K, Koralnik IJ. Prospective Cohort Study on Performance of Cerebrospinal Fluid (CSF) Xpert MTB/RIF, CSF Lipoarabinomannan (LAM) Lateral Flow Assay (LFA), and Urine LAM LFA for Diagnosis of Tuberculous Meningitis in Zambia. Journal of clinical microbiology. 2019 Aug:57(8):. doi: 10.1128/JCM.00652-19. Epub 2019 Jul 26
[PubMed PMID: 31189584]
Level 2 (mid-level) evidence
[37]
Wen A, Leng EL, Liu SM, Zhou YL, Cao WF, Yao DY, Hu F. Diagnostic Accuracy of Interferon-Gamma Release Assays for Tuberculous Meningitis: A Systematic Review and Meta-Analysis. Frontiers in cellular and infection microbiology. 2022:12():788692. doi: 10.3389/fcimb.2022.788692. Epub 2022 Apr 22
[PubMed PMID: 35531329]
Level 1 (high-level) evidence
[38]
Shi F, Qiu X, Yu M, Huang Y. Tuberculosis-specific antigen stimulated and unstimulated interferon-γ for tuberculous meningitis diagnosis: A systematic review and meta-analysis. PloS one. 2022:17(8):e0273834. doi: 10.1371/journal.pone.0273834. Epub 2022 Aug 30
[PubMed PMID: 36040925]
Level 2 (mid-level) evidence
[39]
Chen Y, Wang Y, Liu X, Li W, Fu H, Liu X, Zhang X, Zhou X, Yang B, Yao J, Ma X, Han L, Li H, Zheng L. Comparative diagnostic utility of metagenomic next-generation sequencing, GeneXpert, modified Ziehl-Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi-center, retrospective study in China. Journal of clinical laboratory analysis. 2022 Apr:36(4):e24307. doi: 10.1002/jcla.24307. Epub 2022 Feb 24
[PubMed PMID: 35202495]
Level 2 (mid-level) evidence
[40]
Lin BW, Hong JC, Jiang ZJ, Zhang WQ, Fan QC, Yao XP. Performance of metagenomic next-generation sequencing in cerebrospinal fluid for diagnosis of tuberculous meningitis. Journal of medical microbiology. 2024 Mar:73(3):. doi: 10.1099/jmm.0.001818. Epub
[PubMed PMID: 38506717]
[41]
Sun Q, Sha W, Xiao HP, Tian Q, Zhu H. Evaluation of cerebrospinal fluid adenosine deaminase activity for the differential diagnosis of tuberculous and nontuberculous meningitis. The American journal of the medical sciences. 2012 Aug:344(2):116-21. doi: 10.1097/MAJ.0b013e318238fee3. Epub
[PubMed PMID: 22104430]
[42]
Rana SV, Chacko F, Lal V, Arora SK, Parbhakar S, Sharma SK, Singh K. To compare CSF adenosine deaminase levels and CSF-PCR for tuberculous meningitis. Clinical neurology and neurosurgery. 2010 Jun:112(5):424-30. doi: 10.1016/j.clineuro.2010.02.012. Epub 2010 Mar 29
[PubMed PMID: 20347212]
[43]
Chaudhary V, Bano S, Garga UC. Central Nervous System Tuberculosis: An Imaging Perspective. Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes. 2017 May:68(2):161-170. doi: 10.1016/j.carj.2016.10.007. Epub 2017 Mar 7
[PubMed PMID: 28283299]
Level 3 (low-level) evidence
[44]
Garg RK, Malhotra HS, Jain A. Neuroimaging in tuberculous meningitis. Neurology India. 2016 Mar-Apr:64(2):219-27. doi: 10.4103/0028-3886.177608. Epub
[PubMed PMID: 26954796]
[45]
Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatric radiology. 2004 Nov:34(11):876-85
[PubMed PMID: 15378213]
[46]
Botha H, Ackerman C, Candy S, Carr JA, Griffith-Richards S, Bateman KJ. Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis. PloS one. 2012:7(6):e38982. doi: 10.1371/journal.pone.0038982. Epub 2012 Jun 29
[PubMed PMID: 22768055]
[47]
Garg RK, Paliwal V, Malhotra HS. Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis. Expert review of anti-infective therapy. 2011 Sep:9(9):719-29. doi: 10.1586/eri.11.93. Epub
[PubMed PMID: 21905782]
[48]
Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, De Roeck J, Coeman V, De Schepper AM. Tuberculosis of the central nervous system: overview of neuroradiological findings. European radiology. 2003 Aug:13(8):1876-90
[PubMed PMID: 12942288]
Level 3 (low-level) evidence
[49]
Soni N, Kumar S, Shimle A, Ora M, Bathla G, Mishra P. Cerebrovascular complications in tuberculous meningitis-A magnetic resonance imaging study in 90 patients from a tertiary care hospital. The neuroradiology journal. 2020 Feb:33(1):3-16. doi: 10.1177/1971400919881188. Epub 2019 Oct 7
[PubMed PMID: 31589101]
[50]
Kalita J, Misra UK, Nair PP. Predictors of stroke and its significance in the outcome of tuberculous meningitis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 2009 Jul-Aug:18(4):251-8. doi: 10.1016/j.jstrokecerebrovasdis.2008.11.007. Epub
[PubMed PMID: 19560677]
[51]
Shukla R, Abbas A, Kumar P, Gupta RK, Jha S, Prasad KN. Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. The Journal of infection. 2008 Oct:57(4):298-306. doi: 10.1016/j.jinf.2008.07.012. Epub 2008 Aug 28
[PubMed PMID: 18760486]
[52]
Wasay M, Kheleani BA, Moolani MK, Zaheer J, Pui M, Hasan S, Muzaffar S, Bakshi R, Sarawari AR. Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2003 Jul:13(3):240-7
[PubMed PMID: 12889171]
[53]
Bargalló J, Berenguer J, García-Barrionuevo J, Ubeda B, Bargalló N, Cardenal C, Mercader JM. The "target sign": is it a specific sign of CNS tuberculoma? Neuroradiology. 1996 Aug:38(6):547-50
[PubMed PMID: 8880716]
[54]
Parry AH, Wani AH, Shaheen FA, Wani AA, Feroz I, Ilyas M. Evaluation of intracranial tuberculomas using diffusion-weighted imaging (DWI), magnetic resonance spectroscopy (MRS) and susceptibility weighted imaging (SWI). The British journal of radiology. 2018 Nov:91(1091):20180342. doi: 10.1259/bjr.20180342. Epub 2018 Jul 23
[PubMed PMID: 29987985]
[55]
Garg RK, Malhotra HS, Gupta R. Spinal cord involvement in tuberculous meningitis. Spinal cord. 2015 Sep:53(9):649-57. doi: 10.1038/sc.2015.58. Epub 2015 Apr 21
[PubMed PMID: 25896347]
[56]
Gupta R, Garg RK, Jain A, Malhotra HS, Verma R, Sharma PK. Spinal cord and spinal nerve root involvement (myeloradiculopathy) in tuberculous meningitis. Medicine. 2015 Jan:94(3):e404. doi: 10.1097/MD.0000000000000404. Epub
[PubMed PMID: 25621686]
[57]
Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Oct 1:63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10
[PubMed PMID: 27516382]
Level 1 (high-level) evidence
[58]
Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. The Journal of infection. 2009 Sep:59(3):167-87. doi: 10.1016/j.jinf.2009.06.011. Epub 2009 Jul 4
[PubMed PMID: 19643501]
[59]
. WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-susceptible tuberculosis treatment. 2022:():
[PubMed PMID: 35727905]
[60]
Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, Sarin R, Paramasivan CN, Kumar P, Nischal N, Khatiwada S, Garner P, Tharyan P. Index-TB guidelines: Guidelines on extrapulmonary tuberculosis for India. The Indian journal of medical research. 2017 Apr:145(4):448-463. doi: 10.4103/ijmr.IJMR_1950_16. Epub
[PubMed PMID: 28862176]
[61]
Thwaites GE, Bhavnani SM, Chau TT, Hammel JP, Török ME, Van Wart SA, Mai PP, Reynolds DK, Caws M, Dung NT, Hien TT, Kulawy R, Farrar J, Ambrose PG. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrobial agents and chemotherapy. 2011 Jul:55(7):3244-53. doi: 10.1128/AAC.00064-11. Epub 2011 Apr 18
[PubMed PMID: 21502621]
Level 1 (high-level) evidence
[62]
Heemskerk AD, Bang ND, Mai NT, Chau TT, Phu NH, Loc PP, Chau NV, Hien TT, Dung NH, Lan NT, Lan NH, Lan NN, Phong le T, Vien NN, Hien NQ, Yen NT, Ha DT, Day JN, Caws M, Merson L, Thinh TT, Wolbers M, Thwaites GE, Farrar JJ. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. The New England journal of medicine. 2016 Jan 14:374(2):124-34. doi: 10.1056/NEJMoa1507062. Epub
[PubMed PMID: 26760084]
[63]
Peloquin CA, Davies GR. The Treatment of Tuberculosis. Clinical pharmacology and therapeutics. 2021 Dec:110(6):1455-1466. doi: 10.1002/cpt.2261. Epub 2021 Jun 5
[PubMed PMID: 33837535]
[64]
Li Y, Sun F, Zhang W. Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging. Drug development research. 2019 Feb:80(1):98-105. doi: 10.1002/ddr.21498. Epub 2018 Dec 11
[PubMed PMID: 30548290]
[65]
Dian S, Ganiem AR, van Laarhoven A. Central nervous system tuberculosis. Current opinion in neurology. 2021 Jun 1:34(3):396-402. doi: 10.1097/WCO.0000000000000920. Epub
[PubMed PMID: 33661159]
Level 3 (low-level) evidence
[66]
Marais S, Van Toorn R, Chow FC, Manesh A, Siddiqi OK, Figaji A, Schoeman JF, Meintjes G, Tuberculous Meningitis International Research Consortium. Management of intracranial tuberculous mass lesions: how long should we treat for? Wellcome open research. 2019:4():158. doi: 10.12688/wellcomeopenres.15501.2. Epub 2019 Oct 31
[PubMed PMID: 32047859]
Level 2 (mid-level) evidence
[67]
Khatri GD, Krishnan V, Antil N, Saigal G. Magnetic resonance imaging spectrum of intracranial tubercular lesions: one disease, many faces. Polish journal of radiology. 2018:83():e524-e535. doi: 10.5114/pjr.2018.81408. Epub 2018 Dec 29
[PubMed PMID: 30800191]
[68]
Suárez I, Gruell H, Heyckendorf J, Fünger S, Lichtenstein T, Jung N, Lehmann C, Unnewehr M, Fätkenheuer G, Lange C, Rybniker J. Intensified adjunctive corticosteroid therapy for CNS tuberculomas. Infection. 2020 Apr:48(2):289-293. doi: 10.1007/s15010-019-01378-3. Epub 2020 Jan 3
[PubMed PMID: 31900872]
[69]
Pandita A, Madhuripan N, Pandita S, Hurtado RM. Challenges and controversies in the treatment of spinal tuberculosis. Journal of clinical tuberculosis and other mycobacterial diseases. 2020 May:19():100151. doi: 10.1016/j.jctube.2020.100151. Epub 2020 Feb 28
[PubMed PMID: 32154388]
[70]
Rathod TN, Sathe AH, Marathe NA. It's Never Too Late: Neurological Outcome of Delayed Decompression in Tuberculosis of Spine. Global spine journal. 2021 Jun:11(5):716-721. doi: 10.1177/2192568220922209. Epub 2020 May 19
[PubMed PMID: 32875909]
[71]
Yong LN, Ahmedy F, Yin KN, Engkasan JP. Functional Outcomes in Spinal Tuberculosis: A Review of the Literature. Asian spine journal. 2021 Jun:15(3):381-391. doi: 10.31616/asj.2020.0086. Epub 2020 Sep 22
[PubMed PMID: 32951405]
[72]
Wang W, Gao J, Liu J, Qi J, Zhang Q. Clinical Efficacy of Dexamethasone in the Treatment of Patients with Tuberculous Meningitis: A Meta-Analysis. Contrast media & molecular imaging. 2022:2022():2180374. doi: 10.1155/2022/2180374. Epub 2022 Mar 30
[PubMed PMID: 35418812]
Level 1 (high-level) evidence
[73]
Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. The New England journal of medicine. 2004 Oct 21:351(17):1741-51
[PubMed PMID: 15496623]
[74]
Donovan J, Bang ND, Imran D, Nghia HDT, Burhan E, Huong DTT, Hiep NTT, Ngoc LHB, Thanh DV, Thanh NT, Wardhani ALS, Maharani K, Gasmara CP, Hanh NHH, Oanh PKN, Estiasari R, Thu DDA, Kusumaningrum A, Dung LT, Giang DC, Ha DTM, Lan NH, Chau NVV, Nguyet NTM, Geskus RB, Thuong NTT, Kestelyn E, Hamers RL, Phu NH, Thwaites GE, ACT HIV Investigators. Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults. The New England journal of medicine. 2023 Oct 12:389(15):1357-1367. doi: 10.1056/NEJMoa2216218. Epub
[PubMed PMID: 37819954]
[75]
Gundamraj S, Hasbun R. The Use of Adjunctive Steroids in Central Nervous Infections. Frontiers in cellular and infection microbiology. 2020:10():592017. doi: 10.3389/fcimb.2020.592017. Epub 2020 Nov 23
[PubMed PMID: 33330135]
[76]
Prasad K, Singh MB, Ryan H. Corticosteroids for managing tuberculous meningitis. The Cochrane database of systematic reviews. 2016 Apr 28:4(4):CD002244. doi: 10.1002/14651858.CD002244.pub4. Epub 2016 Apr 28
[PubMed PMID: 27121755]
Level 1 (high-level) evidence
[77]
Schoeman JF, Andronikou S, Stefan DC, Freeman N, van Toorn R. Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases. Journal of child neurology. 2010 Jul:25(7):822-8. doi: 10.1177/0883073809350507. Epub 2010 Jun 2
[PubMed PMID: 20519667]
Level 3 (low-level) evidence
[78]
Jorge JH, Graciela C, Pablo AP, Luis SH. A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2012 Jun:18(4):189-91. doi: 10.1097/RHU.0b013e318258b725. Epub
[PubMed PMID: 22647865]
[79]
Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. Journal of the neurological sciences. 2010 Jun 15:293(1-2):12-7. doi: 10.1016/j.jns.2010.03.025. Epub 2010 Apr 24
[PubMed PMID: 20421121]
Level 1 (high-level) evidence
[80]
Donovan J, Figaji A, Imran D, Phu NH, Rohlwink U, Thwaites GE. The neurocritical care of tuberculous meningitis. The Lancet. Neurology. 2019 Aug:18(8):771-783. doi: 10.1016/S1474-4422(19)30154-1. Epub 2019 May 17
[PubMed PMID: 31109897]
[81]
Nagotkar L, Shanbag P, Dasarwar N. Cerebral salt wasting syndrome following neurosurgical intervention in tuberculous meningitis. Indian pediatrics. 2008 Jul:45(7):598-601
[PubMed PMID: 18695284]
[82]
Misra UK, Kalita J, Tuberculous Meningitis International Research Consortium. Mechanism, spectrum, consequences and management of hyponatremia in tuberculous meningitis. Wellcome open research. 2019:4():189. doi: 10.12688/wellcomeopenres.15502.2. Epub 2021 Mar 29
[PubMed PMID: 32734004]
[83]
Dian S, Hermawan R, van Laarhoven A, Immaculata S, Achmad TH, Ruslami R, Anwary F, Soetikno RD, Ganiem AR, van Crevel R. Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis. PloS one. 2020:15(11):e0241974. doi: 10.1371/journal.pone.0241974. Epub 2020 Nov 13
[PubMed PMID: 33186351]
[84]
Singh AK, Malhotra HS, Garg RK, Jain A, Kumar N, Kohli N, Verma R, Sharma PK. Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis. BMC infectious diseases. 2016 Jun 21:16():306. doi: 10.1186/s12879-016-1625-9. Epub 2016 Jun 21
[PubMed PMID: 27329253]
[85]
Quinn CM, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell FV, Bahr NC. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life (Basel, Switzerland). 2020 Oct 29:10(11):. doi: 10.3390/life10110262. Epub 2020 Oct 29
[PubMed PMID: 33138069]
[86]
Garg RK, Malhotra HS, Kumar N. Paradoxical reaction in HIV negative tuberculous meningitis. Journal of the neurological sciences. 2014 May 15:340(1-2):26-36. doi: 10.1016/j.jns.2014.03.025. Epub 2014 Mar 19
[PubMed PMID: 24680563]
[87]
Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. The Indian journal of medical research. 2005 Apr:121(4):550-67
[PubMed PMID: 15817963]
[88]
Rajshekhar V. Management of hydrocephalus in patients with tuberculous meningitis. Neurology India. 2009 Jul-Aug:57(4):368-74. doi: 10.4103/0028-3886.55572. Epub
[PubMed PMID: 19770534]
[89]
Yadav YR, Parihar VS, Todorov M, Kher Y, Chaurasia ID, Pande S, Namdev H. Role of endoscopic third ventriculostomy in tuberculous meningitis with hydrocephalus. Asian journal of neurosurgery. 2016 Oct-Dec:11(4):325-329
[PubMed PMID: 27695532]
[90]
Suryaningtyas W, Ranuh IGMAR, Parenrengi MA. Shunt exposure as a ventriculoperitoneal shunt complication: A case series. International journal of surgery case reports. 2021 Feb:79():484-491. doi: 10.1016/j.ijscr.2021.01.084. Epub 2021 Jan 27
[PubMed PMID: 33757268]
Level 2 (mid-level) evidence
[91]
Kumar A, Singh K, Sharma V. Surgery in hydrocephalus of tubercular origin: challenges and management. Acta neurochirurgica. 2013 May:155(5):869-73. doi: 10.1007/s00701-013-1658-4. Epub 2013 Mar 16
[PubMed PMID: 23504056]
[92]
Rizvi I, Garg RK, Malhotra HS, Kumar N, Sharma E, Srivastava C, Uniyal R. Ventriculo-peritoneal shunt surgery for tuberculous meningitis: A systematic review. Journal of the neurological sciences. 2017 Apr 15:375():255-263. doi: 10.1016/j.jns.2017.02.008. Epub 2017 Feb 4
[PubMed PMID: 28320142]
Level 1 (high-level) evidence
[93]
Rajshekhar V. Three Decades of Vellore Grading for Tuberculous Meningitis with Hydrocephalus: A Reappraisal. Neurology India. 2021 Nov-Dec:69(Supplement):S569-S574. doi: 10.4103/0028-3886.332251. Epub
[PubMed PMID: 35103015]
[94]
Arshad A, Dayal S, Gadhe R, Mawley A, Shin K, Tellez D, Phan P, Venketaraman V. Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment. Journal of clinical medicine. 2020 Sep 14:9(9):. doi: 10.3390/jcm9092962. Epub 2020 Sep 14
[PubMed PMID: 32937808]
[95]
Ssebambulidde K, Gakuru J, Ellis J, Cresswell FV, Bahr NC. Improving Technology to Diagnose Tuberculous Meningitis: Are We There Yet? Frontiers in neurology. 2022:13():892224. doi: 10.3389/fneur.2022.892224. Epub 2022 May 30
[PubMed PMID: 35711276]
[96]
van Laarhoven A, Dian S, van Dorp S, Purnama F, Koeken VACM, Diandini E, Utami F, Livia R, Apriani L, Ardiansyah E, Ter Horst R, Netea MG, Achmad TH, Hill PC, Ruslami R, Alisjahbana B, Ussher JE, Indrati A, Verrall A, Ganiem AR, van Crevel R. Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study. Scientific reports. 2019 Jan 29:9(1):884. doi: 10.1038/s41598-018-36696-3. Epub 2019 Jan 29
[PubMed PMID: 30696839]
[97]
Colas RA, Nhat LTH, Thuong NTT, Gómez EA, Ly L, Thanh HH, Mai NTH, Phu NH, Thwaites GE, Dalli J. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019 Nov:33(11):13028-13039. doi: 10.1096/fj.201901590R. Epub 2019 Oct 5
[PubMed PMID: 31500466]
[98]
Ashta A, Prakash A, Dixit R, Kumar N. Cerebrospinal Fluid Flow Analysis in Tuberculous Meningitis Using Phase Contrast Technique on 3 Tesla MRI: A New Paradigm and Our Initial Experience. Neurology India. 2022 May-Jun:70(3):1025-1031. doi: 10.4103/0028-3886.349627. Epub
[PubMed PMID: 35864634]
[99]
Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M, Nix-TB Trial Team. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. The New England journal of medicine. 2020 Mar 5:382(10):893-902. doi: 10.1056/NEJMoa1901814. Epub
[PubMed PMID: 32130813]
[100]
Saylor D. Neurologic Complications of Tuberculosis. Continuum (Minneapolis, Minn.). 2021 Aug 1:27(4):992-1017. doi: 10.1212/CON.0000000000001005. Epub
[PubMed PMID: 34623101]
[101]
Mai NTH, Dobbs N, Phu NH, Colas RA, Thao LTP, Thuong NTT, Nghia HDT, Hanh NHH, Hang NT, Heemskerk AD, Day JN, Ly L, Thu DDA, Merson L, Kestelyn E, Wolbers M, Geskus R, Summers D, Chau NVV, Dalli J, Thwaites GE. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. eLife. 2018 Feb 27:7():. doi: 10.7554/eLife.33478. Epub 2018 Feb 27
[PubMed PMID: 29482717]
Level 1 (high-level) evidence
[102]
Pan Z, Zhang J, Bu Q, He H, Bai L, Yang J, Liu Q, Lyu J. The Gap Between Global Tuberculosis Incidence and the First Milestone of the WHO End Tuberculosis Strategy: An Analysis Based on the Global Burden of Disease 2017 Database. Infection and drug resistance. 2020:13():1281-1286. doi: 10.2147/IDR.S248875. Epub 2020 May 4
[PubMed PMID: 32440164]
[103]
Chakaya J, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, Lungu P, Ntoumi F, Kumarasamy N, Maeurer M, Zumla A. The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2022 Nov:124 Suppl 1():S26-S29. doi: 10.1016/j.ijid.2022.03.011. Epub 2022 Mar 20
[PubMed PMID: 35321845]
[104]
Forget EJ, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert opinion on drug safety. 2006 Mar:5(2):231-49
[PubMed PMID: 16503745]
Level 3 (low-level) evidence
[105]
Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chawla YK. A guide to the management of tuberculosis in patients with chronic liver disease. Journal of clinical and experimental hepatology. 2012 Sep:2(3):260-70. doi: 10.1016/j.jceh.2012.07.007. Epub 2012 Sep 21
[PubMed PMID: 25755442]
[106]
Abbara A, Chitty S, Roe JK, Ghani R, Collin SM, Ritchie A, Kon OM, Dzvova J, Davidson H, Edwards TE, Hateley C, Routledge M, Buckley J, Davidson RN, John L. Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK. BMC infectious diseases. 2017 Mar 24:17(1):231. doi: 10.1186/s12879-017-2330-z. Epub 2017 Mar 24
[PubMed PMID: 28340562]
Level 2 (mid-level) evidence
[108]
Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clinical microbiology reviews. 2008 Apr:21(2):243-61, table of contents. doi: 10.1128/CMR.00042-07. Epub
[PubMed PMID: 18400795]
[109]
Wang MG, Luo L, Zhang Y, Liu X, Liu L, He JQ. Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis. BMC pulmonary medicine. 2019 Nov 6:19(1):200. doi: 10.1186/s12890-019-0966-8. Epub 2019 Nov 6
[PubMed PMID: 31694599]
Level 1 (high-level) evidence
[110]
George EL, Iype T, Cherian A, Chandy S, Kumar A, Balakrishnan A, Vijayakumar K. Predictors of mortality in patients with meningeal tuberculosis. Neurology India. 2012 Jan-Feb:60(1):18-22. doi: 10.4103/0028-3886.93583. Epub
[PubMed PMID: 22406774]
[111]
Jiang Y, Xu X, Guo Z, Liu Y, Lin J, Suo L, Jiang Y, Liu B, Lu T. Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome. Frontiers in neurology. 2022:13():830029. doi: 10.3389/fneur.2022.830029. Epub 2022 Mar 16
[PubMed PMID: 35370906]
[112]
Quinn CM, Kasibante J, Namudde A, Bangdiwala AS, Kabahubya M, Nakasujja N, Lofgren S, Elliott A, Boulware DR, Meya DB, Cresswell FV. Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort. Wellcome open research. 2021:6():208. doi: 10.12688/wellcomeopenres.16967.2. Epub 2022 Mar 3
[PubMed PMID: 35949653]
[113]
Rasouli MR, Mirkoohi M, Vaccaro AR, Yarandi KK, Rahimi-Movaghar V. Spinal tuberculosis: diagnosis and management. Asian spine journal. 2012 Dec:6(4):294-308. doi: 10.4184/asj.2012.6.4.294. Epub 2012 Dec 14
[PubMed PMID: 23275816]
[114]
Garg RK, Somvanshi DS. Spinal tuberculosis: a review. The journal of spinal cord medicine. 2011:34(5):440-54. doi: 10.1179/2045772311Y.0000000023. Epub
[PubMed PMID: 22118251]
[115]
Koplay M, Erdogan H, Sivri M, Nayman A, Paksoy Y. Unusual reason of spinal cord infarction: tuberculous meningitis. Acta neurologica Belgica. 2016 Mar:116(1):87-9. doi: 10.1007/s13760-015-0507-z. Epub 2015 Jul 5
[PubMed PMID: 26143304]
[116]
Cocozza AM, Linh NN, Nathavitharana RR, Ahmad U, Jaramillo E, Gargioni GEM, Fox GJ. An assessment of current tuberculosis patient care and support policies in high-burden countries. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 2020 Jan 1:24(1):36-42. doi: 10.5588/ijtld.19.0183. Epub
[PubMed PMID: 32005305]
[117]
Daftary A, Mitchell EMH, Reid MJA, Fekadu E, Goosby E. To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma. The American journal of tropical medicine and hygiene. 2018 Nov:99(5):1114-1116. doi: 10.4269/ajtmh.18-0591. Epub
[PubMed PMID: 30226149]
[118]
Tang ZQ, Jiang RH, Xu HB. Effectiveness of pharmaceutical care on treatment outcomes for patients with first-time pulmonary tuberculosis in China. Journal of clinical pharmacy and therapeutics. 2018 Dec:43(6):888-894. doi: 10.1111/jcpt.12746. Epub 2018 Jul 12
[PubMed PMID: 30003561]
[119]
Muthu V, Agarwal R, Dhooria S, Aggarwal AN, Behera D, Sehgal IS. Outcome of Critically Ill Subjects With Tuberculosis: Systematic Review and Meta-Analysis. Respiratory care. 2018 Dec:63(12):1541-1554. doi: 10.4187/respcare.06190. Epub 2018 Sep 11
[PubMed PMID: 30206126]
Level 1 (high-level) evidence
[120]
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O'Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM, Sterling TR, Warshauer DM, Woods GL. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 Jan 15:64(2):111-115. doi: 10.1093/cid/ciw778. Epub
[PubMed PMID: 28052967]
Level 1 (high-level) evidence